Onco-Innovations Files Preliminary Base Shelf Prospectus

Onco-Innovations Limited has announced the filing of a preliminary base shelf prospectus with securities regulators in Alberta, British Columbia, Manitoba, and Ontario. This step allows the potential issuance of various securities, such as common shares and debt securities, over a 25-month period. However, sales are contingent upon the receipt of a final prospectus and subsequent supplements detailing specific offerings.

The company emphasizes that the filing aims to enhance financial flexibility, though there is no guarantee of any securities being sold under this prospectus. The securities will not be registered in the United States and cannot be offered there without specific exceptions.

A copy of the base shelf prospectus is available on SEDAR+. This move forms part of Onco-Innovations' strategy to support its mission in pioneering cancer research and treatment technologies.